Clinical trial
Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder
NCT03554174 is registered in ClinicalTrials.gov with Yale University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder
- Lead sponsor
- Yale University
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- February 27, 2018
- Completion date
- September 30, 2026
- Enrollment
- 18 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.